In our study, the expression of BUB1 mRNA was significantly elevated in the central nervous system, bladder, cervical, brain, ovarian, breast, gastric, colorectal, esophageal, head, pancreatic, liver, neck, lung, and prostate cancers, as well as lymphomas and sarcomas. Here, BUB1 is linked to prostate cancer.